HTG Molecular Diagnostics, Inc. (HTGM) has a consensus analyst rating of Buy, based on 8 analysts covering the stock. Of those, 8 recommend buying, 0 recommend holding, and 0 recommend selling.
The analyst consensus price target for HTGM is $0.17, representing a -65.3% downside from the current price of $0.48. Price targets range from a low of $0.17 to a high of $0.17.
